{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:39:11Z","timestamp":1762144751106},"reference-count":33,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1973,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1111\/j.1755-5949.2009.00131.x","type":"journal-article","created":{"date-parts":[[2010,12,20]],"date-time":"2010-12-20T14:39:43Z","timestamp":1292855983000},"page":"148-157","source":"Crossref","is-referenced-by-count":6,"title":["Imidazolium Salt (DBZIM) Reduces Gliosis in Mice Treated with Neurotoxicant 2\u2032-CH3-MPTP"],"prefix":"10.1111","volume":"17","author":[{"given":"Gideon","family":"Ho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saravana","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyuan","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh Hiu Nam","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur-Afidah Mohamed","family":"Suhaimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin Ling","family":"Kng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yugen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lang","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,4,7]]},"reference":[{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1093\/hmg\/11.26.3351","article-title":"Progressive retinal degeneration and dysfunction in R6 Huntington's disease mice","volume":"11","author":"Helmlinger","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","article-title":"The Parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): A technical review of its utility and safety","volume":"76","author":"Przedborski","year":"2001","journal-title":"J Neurochem"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","article-title":"Toxin-induced models of Parkinson's disease","volume":"2","author":"Bove","year":"2005","journal-title":"NeuroRx"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/glia.20233","article-title":"Glia cell number modulates sensitivity to MPTP in mice","volume":"52","author":"Smeyne","year":"2005","journal-title":"Glia"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0166-2236(90)90113-O","article-title":"Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients","volume":"13","author":"Bodis-Wollner","year":"1990","journal-title":"Trends Neurosci"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1748-1716.1965.tb04153.x","article-title":"Identification and cellular localization of the catecholamines in the retina and the choroid of the rabbit","volume":"64","author":"Haeggendal","year":"1965","journal-title":"Acta Physiol Scand"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1126\/science.30997","article-title":"Light stimulates tyrosine hydroxylase activity and dopamine synthesis in retinal amacrine neurons","volume":"202","author":"Iuvone","year":"1978","journal-title":"Science"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0014-4835(85)90073-9","article-title":"Responses of the pigmented rabbit retina to NMPTP, a chemical inducer of Parkinsonism","volume":"40","author":"Wong","year":"1985","journal-title":"Exp Eye Res"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0304-3940(86)90084-4","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment decreases dopamine and increases lipofuscin in mouse retina","volume":"72","author":"Mariani","year":"1986","journal-title":"Neurosci Lett"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1023\/A:1023298604347","article-title":"The retina as a novel in vivo model for studying the role of molecules of the Bcl-2 family in relation to MPTP neurotoxicity","volume":"28","author":"Chen","year":"2003","journal-title":"Neurochem Res"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/cne.20761","article-title":"Morphological impairments in retinal neurons of the scotopic visual pathway in a monkey model of Parkinson's disease","volume":"493","author":"Cuenca","year":"2005","journal-title":"J Comp Neurol"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/78774","article-title":"Control of Muller glial cell proliferation and activation following retinal injury","volume":"3","author":"Dyer","year":"2000","journal-title":"Nature Neurosci"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB13|cit13","first-page":"197","article-title":"Assessment of neurotoxicity: Use of glial fibrillary acidic protein as a biomarker","volume":"4","author":"O\u2019Callaghan","year":"1991","journal-title":"Biomed Environ Sci"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1167\/iovs.08-2133","article-title":"Molecular imaging of retinal gliosis in transgenic mice induced by kainic acid neurotoxicity","volume":"50","author":"Ho","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1364\/OE.16.008250","article-title":"Achieving cellular resolution for in vivo retinal images of transgenic GFAP-GFP mice via image processing","volume":"16","author":"Kumar","year":"2008","journal-title":"Opt Exp"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1006\/dbio.1997.8601","article-title":"Live astrocytes visualized by green fluorescent protein in transgenic mice","volume":"187","author":"Zhuo","year":"1997","journal-title":"Dev Biol"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1016\/j.visres.2005.08.014","article-title":"In vivo confocal imaging of the retina in animal models using scanning laser ophthalmoscopy","volume":"45","author":"Seeliger","year":"2005","journal-title":"Vision Res"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"12586","DOI":"10.1021\/ja8037883","article-title":"Imidazolium salts: A mild reducing and antioxidative reagent","volume":"130","author":"Zhao","year":"2008","journal-title":"J Am Chem Soc"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jbt.20053","article-title":"Potential neuroprotective effect of t-butylhydroquinone against neurotoxicity\u2212induced by 1-methyl-4-(2\u2032-methylphenyl)-1,2,3,6-tetrahydropyridine (2\u2032-methyl-MPTP) in mice","volume":"19","author":"Abdel-Wahab","year":"2005","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB20|cit20","volume-title":"The mouse brain in stereotaxic coordinates","author":"Franklin","year":"2001"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.taap.2005.02.039","article-title":"Insights into Parkinson's disease models and neurotoxicity using non-invasive imaging","volume":"207","author":"Sanchez-Pernaute","year":"2005","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0892-0362(88)90006-2","article-title":"Neurotypic and gliotypic proteins as biochemical markers of neurotoxicity","volume":"10","author":"O\u2019Callaghan","year":"1998","journal-title":"Neurotoxicol Teratol"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nbd.2006.02.003","article-title":"5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson's disease","volume":"23","author":"Bezard","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","article-title":"Etiology and pathogenesis of Parkinson's disease","volume":"22","author":"Olanow","year":"1999","journal-title":"Annu Rev Neurosci"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: Mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"Suppl 1","key":"10.1111\/j.1755-5949.2009.00131.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.parkreldis.2004.10.013","article-title":"Neuroinflammatory processes in Parkinson's disease","volume":"11","author":"Hirsch","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"29194","DOI":"10.1074\/jbc.M500984200","article-title":"Superoxide dismutase\/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra: Implications for Parkinson disease","volume":"280","author":"Peng","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2001.00397.x","article-title":"Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: Effect of R-apomorphine","volume":"78","author":"Grunblatt","year":"2001","journal-title":"J Neurochem"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","article-title":"Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from Parkinsonian patients","volume":"180","author":"Mogi","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00002512-199914020-00004","article-title":"The role of iron in neurodegeneration: Prospects for pharmacotherapy of Parkinson's disease","volume":"14","author":"Jellinger","year":"1999","journal-title":"Drugs Aging"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1046\/j.1471-4159.2001.00490.x","article-title":"Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration","volume":"78","author":"Levites","year":"2001","journal-title":"J Neurochem"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0161-813X(02)00079-7","article-title":"Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate","volume":"23","author":"Choi","year":"2002","journal-title":"Neurotoxicology"},{"key":"10.1111\/j.1755-5949.2009.00131.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2165\/00023210-200519090-00001","article-title":"Treatment of Parkinson's disease: What's on the horizon?","volume":"19","author":"Wu","year":"2005","journal-title":"CNS Drugs"}],"container-title":["CNS Neuroscience &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1755-5949.2009.00131.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1755-5949.2009.00131.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T21:28:15Z","timestamp":1612474095000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1111\/j.1755-5949.2009.00131.x"}},"subtitle":["Imidazolium Salt as an Inhibitor of Neurotoxicity"],"short-title":[],"issued":{"date-parts":[[2010,4,7]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1755-5949.2009.00131.x","relation":{},"ISSN":["1755-5930"],"issn-type":[{"value":"1755-5930","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4,7]]}}}